Back
Outlook Therapeutics Stock Price Chart
Zero Day Options Trade LIVE Tuesday at 2 p.m. ET!
Discover The Zero Day Loophole (BEFORE Tues at 2 p.m. ET!)
Sell
5
OTLK
Outlook Therapeutics
Last Price:
1.54
Seasonality Move:
10.95%
7 Day Trial
ALL ACCESS PASS
$
7
Better Than Oil Stocks
CLICK HERE TO FIND OUT MORE- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and OTLK is experiencing slight buying pressure.
Outlook Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.67 | Sell |
| 20-day SMA: | 3.48 | Sell |
| 50-day SMA: | 4.75 | Sell |
| 200-day SMA: | 6.97 | Sell |
| 8-day EMA: | 1.93 | Sell |
| 20-day EMA: | 3.07 | Sell |
| 50-day EMA: | 4.44 | Sell |
| 200-day EMA: | 7.17 | Sell |
Outlook Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.12 | Sell |
| Relative Strength Index (14 RSI): | 20.52 | Sell |
| Chaikin Money Flow: | 135632 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.08 - 6.06) | Sell |
| Bollinger Bands (100): | (4.18 - 7.64) | Sell |
Outlook Therapeutics Technical Analysis
| Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Outlook Therapeutics Stock
Is Outlook Therapeutics Stock a Buy?
- Outlook Therapeutics share price is 1.57 while OTLK 8-day simple moving average is 1.67, which is a Sell signal.
- The stock price of OTLK is 1.57 while Outlook Therapeutics 20-day SMA is 3.48, which makes it a Sell.
- Outlook Therapeutics 50-day simple moving average is 4.75 while OTLK share price is 1.57, making it a Sell technically.
- OTLK stock price is 1.57 and Outlook Therapeutics 200-day simple moving average is 6.97, creating a Sell signal.
OTLK Technical Analysis vs Fundamental Analysis
Sell
5
Outlook Therapeutics (OTLK)
is a Sell
Is Outlook Therapeutics a Buy or a Sell?
-
Outlook Therapeutics stock is rated a Sell
The current Outlook Therapeutics [OTLK] share price is $1.57. The Score for OTLK is 5, which is 90% below its historic median score of 50, and infers higher risk than normal.
Outlook Therapeutics Stock Info
Market Cap:
37.14M
Price in USD:
1.57
Share Volume:
786.14K
Outlook Therapeutics 52-Week Range
52-Week High:
12.85
52-Week Low:
0.87
Sell
5
Outlook Therapeutics (OTLK)
is a Sell
Outlook Therapeutics Share Price Forecast
-
What is the Outlook Therapeutics stock price today?
The Outlook Therapeutics stock price is 1.57 USD today. -
Will OTLK stock go up or go down?
Outlook Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Outlook Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Outlook Therapeutics is overvalued.
Is Outlook Therapeutics Stock a Buy?
- Outlook Therapeutics share price is 1.57 while OTLK 8-day exponential moving average is 1.93, which is a Sell signal.
- The stock price of OTLK is 1.57 while Outlook Therapeutics 20-day EMA is 3.07, which makes it a Sell.
- Outlook Therapeutics 50-day exponential moving average is 4.44 while OTLK share price is 1.57, making it a Sell technically.
- OTLK stock price is 1.57 and Outlook Therapeutics 200-day simple moving average is 7.17, creating a Sell signal.
Fundamental Analysis of Outlook Therapeutics
Is Outlook Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.39 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.74 per share, and an increase next year of $1.39 per share.
Technical Analysis of Outlook Therapeutics
Should I short Outlook Therapeutics stock?
- OTLK Moving Average Covergence Divergence (MACD) indicator is -1.12, suggesting Outlook Therapeutics is a Sell
- Outlook Therapeutics Relative Strength Index (RSI) is 20.52, which suggest Outlook Therapeutics is oversold
- The Bollinger Bands (25) for Outlook Therapeutics is (2.08 - 6.06), which suggest Outlook Therapeutics is a Sell
- The Bollinger Bands (100) for Outlook Therapeutics is (4.18 - 7.64), which suggest Outlook Therapeutics is a Sell
* Outlook Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.